Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4053 in Seasonal Allergic Rhinitis
NCT01748344Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-4053 in seasonal allergic rhinitis (SAR), sponsored by Ono Pharmaceutical. Started Nov 2012; status: completed.
02
Drugs
ONO-4053
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01748344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748344.